Klotho Neurosciences

(NASDAQ) WENA

Current PriceN/A

Market CapN/A

Since IPO (2022)-95%

5 YearN/A

1 Year+192%

1 Month+46%

Klotho Neurosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$195.80K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

WENA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Klotho Neurosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Joseph Sinkule, PharmD

Website

www.klothoneuro.com

Headquarters

Omaha, NE 68144, US

WENA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-8%

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.30M

EBITDA

$1.30M

Operating Cash Flow

$1.26M

Capital Expenditure

$0.00

Free Cash Flow

$1.26M

Cash & ST Invst.

$172.53K

Total Debt

$1.60M

Klotho Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$451.64K

-194.1%

EBITDA

$395.61K

-62.0%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Net Cash

$3.09M

-313.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.90M

N/A

Short Term Debt

$31.00K

-97.7%

Return on Assets

6.92%

N/A

Return on Invested Capital

-7.59%

N/A

Free Cash Flow

$548.36K

-6.8%

Operating Cash Flow

$424.86K

+17.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMNNImunon, Inc.

IMNNImunon, Inc.$2.80-1.06%

CYADCelyad Oncology S.A.

CYADCelyad Oncology S.A.$0.47-12.96%

PIRSPieris Pharmaceuticals, Inc.

PIRSPieris Pharmaceuticals, Inc.$13.60-15.58%

NYMXFNymox Pharmaceutical Corporation

NYMXFNymox Pharmaceutical Corporation$0.07+9.83%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02+0.42%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.29+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About WENA

What is the current price of Klotho Neurosciences?

Klotho Neurosciences is trading at N/A per share.

What is the 52-week range for Klotho Neurosciences?

Over the past 52 weeks, Klotho Neurosciences has traded between N/A and N/A.

How much debt does Klotho Neurosciences have?

As of the most recent reporting period, Klotho Neurosciences reported total debt of N/A.

How much cash does Klotho Neurosciences have on hand?

Klotho Neurosciences reported $7.18M in cash and cash equivalents in its most recent financial results.

What is Klotho Neurosciences’s dividend yield?

Klotho Neurosciences does not currently have a dividend yield.

Klotho Neurosciences

Klotho Neurosciences Financials at a Glance

WENA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Klotho Neurosciences

WENA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Klotho Neurosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WENA

What is the current price of Klotho Neurosciences?

What is the 52-week range for Klotho Neurosciences?

How much debt does Klotho Neurosciences have?

How much cash does Klotho Neurosciences have on hand?

What is Klotho Neurosciences’s dividend yield?

Premium Investing Services